Calcific uremic arteriolopathy in peritoneal dialysis populations | Canada Hyperbarics Skip to main content
Study Int J Nephrol 2011

Calcific uremic arteriolopathy in peritoneal dialysis populations

New N, Mohandas J, John G, Ratanjee S, Healy H, Francis L, et al. — Int J Nephrol, 2011

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

This study describes calcific uremic arteriolopathy, a serious complication of end-stage kidney disease, and its current treatment approaches.

What They Found

Calcific uremic arteriolopathy is a rare but severe condition characterized by blood vessel calcification, tissue death, and ulcers, often leading to secondary infection and increased mortality. The abstract notes that a combination of local wound care, careful management of calcium and phosphate levels, sodium thiosulfate, and hyperbaric oxygen therapy may be improving the historically poor outlook for this condition.

What This Means for Canadian Patients

For Canadian patients with calcific uremic arteriolopathy, this information highlights the severe nature of the condition and the importance of comprehensive treatment. Hyperbaric oxygen therapy, as part of a multi-pronged approach, may offer a way to improve outcomes for those suffering from this painful and life-threatening complication.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

A limitation noted is that peritoneal dialysis is considered a risk factor for calcific uremic arteriolopathy based on limited evidence, and this link still needs to be definitively proven.

Was this summary helpful?

Study Details

Study Type Study
Category Wound Care
Source Pubmed
PubMed ID 21748002
Year Published 2011
Journal Int J Nephrol

Cite This Study

Share

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.